In one of the first such studies, medical and engineering researchers showed that wearable devices that continuously monitor blood sugar provide new information about the progression of type 2 diabetes in Hispanic / Latin American adults. at risk.
Findings from researchers at Sansum Diabetes Research Institute (SDRI) and Rice University are available online this week at ClinicMedicine, an open access clinical journal published by The Lancet.
“The new look at glucose data sheds new light on disease progression, which could have a direct impact on better management,” said Ashutosh Sabharwal, Rice study co-author, professor and director of the Department of Electrical and Computer Engineering and founder of Rice’s Scalable Health. Laboratories. “An important aspect of our analysis is that the results are clinically interpretable and point to new directions for improving type 2 diabetes care.”
The study builds on the groundbreaking research of IRDS to fight type 2 diabetes in underserved Hispanic / Latin American communities. IRDS’s Farming for Life initiative evaluates the physical and mental health benefits of providing medical prescriptions for local fresh vegetables to people with or at risk for type 2 diabetes, with a focus on the Hispanic community / Latin American. The SDRI recently added a digital health technology called continuous glucose monitoring to this research.
Continuous blood glucose monitors monitor blood glucose 24 hours a day and allow you to view and analyze blood sugar trends over time. The devices typically consist of two parts, a small electrode sensor attached to the skin with an adhesive patch and a receiver that collects data from the sensor.
“We have found that the use of this technology is both feasible and acceptable for this population, primarily Mexican American adults,” said study co-author David Kerr, director of research and research. innovation of the SDRI. “The results also provided new information on measurable differences in glucose profiles for people at risk for type 2 diabetes as well as those not being treated with insulin. These findings could facilitate new therapeutic approaches to reduce the risk of progression to type 2 diabetes population. “
Sabharwal, who is also a co-researcher at the Research Center for Engineering of Precise Advanced Technologies and Health Systems for Under-served Populations (PATHS-UP), said: Health care disparities. “
“We are excited about the application of digital health technologies to underserved populations as a way to eliminate health disparities and improve health equity,” Kerr said. “This opens the potential for more collaborations to support the evolving focus of IRDS on precision nutrition and also the increased use of digital health technologies for the prevention and management of all forms of diabetes.
Source of the story:
Material provided by Rice University. Original written by Jade Boyd. Note: Content can be changed for style and length.